Christine M. Durand

12.8k total citations · 4 hit papers
135 papers, 5.6k citations indexed

About

Christine M. Durand is a scholar working on Infectious Diseases, Epidemiology and Transplantation. According to data from OpenAlex, Christine M. Durand has authored 135 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Infectious Diseases, 47 papers in Epidemiology and 45 papers in Transplantation. Recurrent topics in Christine M. Durand's work include Renal Transplantation Outcomes and Treatments (45 papers), HIV/AIDS drug development and treatment (36 papers) and Hepatitis C virus research (32 papers). Christine M. Durand is often cited by papers focused on Renal Transplantation Outcomes and Treatments (45 papers), HIV/AIDS drug development and treatment (36 papers) and Hepatitis C virus research (32 papers). Christine M. Durand collaborates with scholars based in United States, France and South Africa. Christine M. Durand's co-authors include Robert F. Siliciano, Dorry L. Segev, Gregory M. Laird, Janet D. Siliciano, Allan B. Massie, C. Korin Bullen, Joel N. Blankson, S. Alireza Rabi, Liang Shan and Hao Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Christine M. Durand

125 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation

2012 555 citations Christine M. Durand, Joel N. Blankson et al. profile →
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

1997 514 citations Christine M. Durand et al. Journal of Clinical Oncology profile →
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo

2014 391 citations Christine M. Durand et al. profile →
Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations

2015 308 citations Christine M. Durand et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christine M. Durand United States	37	2.9k	2.0k	1.8k	916	879	135	5.6k
Mary E. Klotman United States	48	2.3k 0.8×	1.6k 0.8×	2.1k 1.2×	293 0.3×	74 0.1×	131	7.3k
Jeffrey Laurence United States	40	2.4k 0.8×	935 0.5×	995 0.6×	137 0.1×	90 0.1×	130	5.4k
Sallie R. Permar United States	35	1.7k 0.6×	2.2k 1.1×	808 0.5×	97 0.1×	112 0.1×	204	4.6k
Harry E. Prince United States	33	1.7k 0.6×	1.1k 0.6×	1.2k 0.7×	166 0.2×	61 0.1×	124	4.1k
Christophe Pasquier France	37	1.8k 0.6×	1.7k 0.9×	1.5k 0.8×	1.1k 1.2×	54 0.1×	135	3.8k
M. Elaine Eyster United States	34	1.5k 0.5×	2.1k 1.1×	1.1k 0.6×	1.7k 1.9×	31 0.0×	124	5.1k
Michaela Lucas Australia	34	501 0.2×	1.4k 0.7×	607 0.3×	1.9k 2.1×	75 0.1×	140	4.2k
Andrzej Horban Poland	34	2.1k 0.7×	2.4k 1.3×	1.2k 0.7×	2.2k 2.4×	25 0.0×	183	4.6k
Carmen de Mendoza Spain	38	3.3k 1.1×	1.7k 0.9×	2.6k 1.5×	1.2k 1.3×	26 0.0×	274	5.1k
Aneesh K. Mehta United States	33	2.0k 0.7×	1.7k 0.9×	159 0.1×	53 0.1×	424 0.5×	90	4.4k

Countries citing papers authored by Christine M. Durand

Since Specialization

Citations

This map shows the geographic impact of Christine M. Durand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine M. Durand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine M. Durand more than expected).

Fields of papers citing papers by Christine M. Durand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine M. Durand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine M. Durand. The network helps show where Christine M. Durand may publish in the future.

Co-authorship network of co-authors of Christine M. Durand

This figure shows the co-authorship network connecting the top 25 collaborators of Christine M. Durand. A scholar is included among the top collaborators of Christine M. Durand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine M. Durand. Christine M. Durand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barnes, Ashley, et al.. (2025). Fatal Donor-Derived KSHV Inflammatory Cytokine Syndrome (KICS) in Lung Transplant. The Journal of Heart and Lung Transplantation. 44(4). S309–S309.

Belga, Sara, et al.. (2025). Hepatitis B Virus Donor Positive to Recipient Negative (D+/R−) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network. Transplant Infectious Disease. 27(5). e70054–e70054.

Ruck, Jessica M., Errol L. Bush, William A. Werbel, et al.. (2025). Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients With Human Immunodeficiency Virus. Transplant Infectious Disease. 27(5). e70090–e70090.

Bowring, Mary G., Jessica M. Ruck, Omar Saeed, et al.. (2025). Potential pool of cardiothoracic organs from donors with HIV. The Journal of Heart and Lung Transplantation. 45(3). 460–467.

Durand, Christine M., Hannah C. Sung, Olivia S. Kates, et al.. (2024). Building a successful transplant research center: Blueprints and barriers. Transplant Infectious Disease. 26(6). e14373–e14373. 1 indexed citations

Durand, Christine M. & Andrew D. Redd. (2024). HOPE springs eternal: lack of HIV superinfection in HIV Organ Policy Equity Act kidney transplants. Journal of Clinical Investigation. 134(20). 1 indexed citations

Durand, Christine M., Mary G. Bowring, Jonathan Hand, et al.. (2024). Influence of induction therapy and antiretroviral regimen on outcomes in kidney transplant recipients living with human immunodeficiency. Transplant Infectious Disease. 26(4). e14287–e14287. 1 indexed citations

Fang, Sandy H., et al.. (2024). Anal dysplasia and anal cancer screening practices among liver transplant centers in the United States: Results of an online survey. Transplant Infectious Disease. 26(4). e14286–e14286. 1 indexed citations

Kim, Ellie, Sarah E. Van Pilsum Rasmussen, Morgan Johnson, et al.. (2024). Patient Perspectives on Solid Organ Transplantation From Donors With Hepatitis C Viremia to Recipients Without Hepatitis C Viremia. Open Forum Infectious Diseases. 11(3). 1 indexed citations

10.

Belga, Sara, Robin K. Avery, Christine M. Durand, et al.. (2023). Impact of recipient age on mortality among Cytomegalovirus (CMV)-seronegative lung transplant recipients with CMV-seropositive donors. The Journal of Heart and Lung Transplantation. 43(4). 615–625. 1 indexed citations

11.

Sise, Meghan E., Min Xu, David S. Goldberg, et al.. (2023). Early initiation of glecaprevir/pibrentasvir after transplantation of HCV‐viremic kidneys into HCV‐negative recipients is associated with normalization in the altered inflammatory milieu. Clinical Transplantation. 37(4). e14926–e14926.

12.

Karaba, Andrew H., Andrew Pekosz, Christine M. Durand, et al.. (2023). Epitope Mapping of SARS-CoV-2 Spike Antibodies in Vaccinated Kidney Transplant Recipients Reveals Poor Spike Coverage Compared to Healthy Controls. The Journal of Infectious Diseases. 229(5). 1366–1371. 2 indexed citations

13.

Permpalung, Nitipong, Teresa Po‐Yu Chiang, Robin K. Avery, et al.. (2023). Coronavirus Disease 2019–Associated Pulmonary Aspergillosis: A Noninvasive Screening Model for Additional Diagnostics. Open Forum Infectious Diseases. 10(4). ofad155–ofad155. 3 indexed citations

14.

Permpalung, Nitipong, Tao Liang, Darin Ostrander, et al.. (2023). Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year. The Journal of Heart and Lung Transplantation. 42(7). 953–963. 5 indexed citations

15.

Ramos, Juan Carlos, Joseph A. Sparano, Amy Chadburn, et al.. (2020). Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 136(11). 1284–1297. 36 indexed citations

16.

Ramos, Juan Carlos, Joseph A. Sparano, Page C. Moore, et al.. (2018). AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL.. Journal of Clinical Oncology. 36(15_suppl). 7573–7573. 2 indexed citations

17.

Kandathil, Abraham J., Sho K. Sugawara, Ashish Goyal, et al.. (2018). No recovery of replication-competent HIV-1 from human liver macrophages. Journal of Clinical Investigation. 128(10). 4501–4509. 35 indexed citations

18.

Durand, Christine M., Mary G. Bowring, Diane Brown, et al.. (2018). Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus–Infected Donors to Noninfected Recipients. Annals of Internal Medicine. 2 indexed citations

19.

Bonifay, Michel, Jean-Paul Ambrosi, Claudio Capelli, et al.. (2016). Étude de la collection Aubert-Buès d’antiquités africaines au musée de Gap : premiers résultats. Antiquités africaines. 52. 157–184. 2 indexed citations

20.

Greene, Reginald E., J W Oestmann, Paul Stark, et al.. (2007). Imaging Findings in Acute Invasive Pulmonary Aspergillosis: Clinical Significance of the Halo Sign. Clinical Infectious Diseases. 44(3). 373–379. 394 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact